Home / Funding Opportunities /
New NOFOs, Notices and other items of potential interest (funding links open in a new tab):
- BRAIN Initiatives:
- BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) (RFA-MH-25-110)
- BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) (RFA-NS-24-016)
- BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) (RFA-NS-24-017)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 – Clinical Trial Not Allowed)(RFA-NS-24-031). Multiple due dates through 2026 and 2027 (check NOFO for details).
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) (PAR-24-160) and New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) (PAR-24-161). Multiple due dates through May 2027.
Standing NOFOs, Notices, and other items of potential interest:
- INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) (RFA-OD-24-007). Due dates July 1, 2024, 2025, and 2026.
- BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)(RFA-MH-25-170) and BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) (RFA-MH-25-171). Due dates through 2026.
- Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) (NOT-OD-24-044). Multiple due dates through February 14, 2025.
- Common Fund initiative: Complement Animal Research In Experimentation (Complement-ARIE) on NAMs (New Approach Methodologies) has been approved: https://commonfund.nih.gov/complementarie
- Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Improve Healthcare for Persons Living with Disabilities (NOT-HS-24-004). Active until Nov. 20, 2025.
- Health and Health Care Disparities Among Persons Living with Disabilities (R01 – Clinical Trials Optional) (PAR-23-309). Application Receipt Date(s): Multiple Dates through November 2026
Click here to view Active Funding Opportunities and Notices for NICHD
